Acesion announces positive atrial fibrillation study
Candidate AP30663 is an inhibitor for the conversion of atrial fibrillation to a…
Candidate AP30663 is an inhibitor for the conversion of atrial fibrillation to a…
Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since…
The type 2 diabetes therapy is being tested on patients in a phase…
Collaboration will concentrate on launching and running studies within medical dermatology LEO Pharma…
Positive results emerge from AEGEAN phase 3 trial for patients with resectable non-small…
FlyPharma Conferences is pleased to announce its seventh event in Europe, which will…
The partnership will concentrate on the development of two investigational antibodies Cancer Research…
Move represents the latest phase of preparation for the opening of MSD’s new…
NICE has recommended the use of semaglutide alongside a reduced-calorie diet and exercise…
Collaboration will focus on innovative therapies for patients with a range of respiratory…